{"status":"success","message":"The STAT_CONC_DEF field for indicator 3-3-4, translated into en","data":"<h1>Concepts and definitions</h1>\n<h2>Definition:</h2>\n<p>This indicator is measured indirectly through the proportion of children 5 years of age who have developed chronic HBV infection (i.e. the proportion that tests positive for a marker of infection called hepatitis B surface antigen [HBsAg]).<sup><a href=\"#footnote-1\" id=\"footnote-ref-1\">[1]</a></sup></p>\n<p> </p>\n<p>Hepatitis B surface antigen: a protein from the virus&#x2019;s coat. A positive test for HBsAg indicates active HBV infection. The immune response to HBsAg provides the basis for immunity against HBV, and HBsAg is the main component of HepB.<sup><a href=\"#footnote-2\" id=\"footnote-ref-2\">[2]</a></sup></p>\n<h2>Concepts:</h2><div class=\"footnotes\"><div><sup class=\"footnote-number\" id=\"footnote-1\">1</sup><p> Global Hepatitis Report 2017. World Health Organization. ISBN 978-92-4-156545-5. <a href=\"#footnote-ref-1\">&#x2191;</a></p></div><div><sup class=\"footnote-number\" id=\"footnote-2\">2</sup><p> Documenting the Impact of Hepatitis B Immunization: best practices for conducting a serosurvey. Immunization, Vaccines and Biologicals. World Health Organization. WHO/IVB/11.08 <a href=\"#footnote-ref-2\">&#x2191;</a></p></div></div>"}